Clinical Trials Sponsored by DJO Incorporated

Total 3212 results

Vertex Pharmaceuticals Incorporated

Completed

A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis

Cystic Fibrosis

United States, Australia, Belgium, Netherlands
Bausch & Lomb Incorporated

Completed

2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses

Contact Lens Wearer

United States
Bausch & Lomb Incorporated

Completed

Evaluation of Surface Refractive Index Shift of Kalifilcon A Lenses Compared to Dailies Total 1, Precision 1 and Biotrue ONEday Lenses

Habitual Soft Contact Lens Use

United States
Vertex Pharmaceuticals Incorporated

Completed

Evaluation of VX 445/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age

Cystic Fibrosis

United States, Canada, Australia, Ireland, United Kingdom
Bausch & Lomb Incorporated

Completed

Bausch & Lomb Ophthalmic Viscosurgical Device (OVD) Dispersive (DVisc40)

Cataract

United States
Castle Biosciences Incorporated

Terminated

5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay Results (INTEGRATE)

Cutaneous Melanoma

United States
Bausch & Lomb Incorporated

Completed

Surface Refractive Index Shift and Lens Absorption/Adsorption of Tear Components of Kalifilcon A Lenses vs Dailies Total1 and Precision1

Habitual Soft Contact Lens Use

United States
Vertex Pharmaceuticals Incorporated

Completed

A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

Cystic Fibrosis

United States, Spain, Ireland, Belgium, Netherlands, United Kingdom, Australia, France, Canada, Denmark, Germany, Italy, Israel
Vertex Pharmaceuticals Incorporated

Completed

A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy

Acute Pain

United States
Torax Medical Incorporated

Completed

An Observational Clinical Feasibility Study of the Magnetic Esophageal Sphincter

Gastroesophageal Reflux Disease

United States, Netherlands, Italy
Bausch & Lomb Incorporated

Completed

Evaluate the Safety and Effectiveness of the Biotrue ONEday for Astigmatism

Astigmatism

United States
Bausch & Lomb Incorporated

Completed

Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.

Allergic Conjunctivitis

United States
Bausch & Lomb Incorporated

Completed

Evaluation of the Feasibility a New Silicone Hydrogel Contact Lens

Myopia

United States
Cook Group Incorporated

Completed

Evaluation of CRB in PROM Patients

Premature Rupture of Fetal Membranes

United States
Bausch & Lomb Incorporated

Completed

Study of T-PRED(TM) Compared to Pred Forte(R) II

Cataract

United States
Bausch & Lomb Incorporated

Completed

Evaluation of Two Daily Disposable Contact Lenses.

Myopia

United States
Bausch & Lomb Incorporated

Completed

Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers

Allergic Conjunctivitis
Bausch & Lomb Incorporated

Completed

Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Bausch & Lomb Incorporated

Completed

Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber

Seasonal Allergic Rhinitis

United States
Bausch & Lomb Incorporated

Completed

A Study to Evaluate a Modified Contact Lens

Myopia

United States
Vertex Pharmaceuticals Incorporated

Terminated

A Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy

Epilepsy

United States, Germany
Bausch & Lomb Incorporated

Completed

Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Pain | Inflammation | Cataract

United States
Bausch & Lomb Incorporated

Completed

Study to Evaluate the Product Performance of a New Silicone Hydrogel Contact Lens

Corneal Deformity

United States
Bausch & Lomb Incorporated

Completed

A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia

Astigmatism | Hyperopia

United States
Bausch & Lomb Incorporated

Completed

Technolas 217z Laser With Zyoptix Aspheric Algorithm Used for the LASIK Treatment of Myopia and Myopic Astigmatism.

Astigmatism | Myopia

Canada
Bausch & Lomb Incorporated

Completed

Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery

Cataract

United States
Bausch & Lomb Incorporated

Completed

Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Inflammation | Cataract | Surgery

United States
Vertex Pharmaceuticals Incorporated

Completed

A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)

Cystic Fibrosis

United States, Belgium, Netherlands, United Kingdom, Canada, Germany, Australia, France, Italy, Czechia, Austria, Greece, Sweden
Vertex Pharmaceuticals Incorporated

Terminated

Study to Assess the Efficacy and Safety of VX-210 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

Cervical Spinal Cord Injury

United States, Canada
Cook Group Incorporated

Approved for marketing

Zenith® TX2® Low Profile TAA Endovascular Graft

Aortic Aneurysm | Vascular Disease | Penetrating Ulcer

United States
Vertex Pharmaceuticals Incorporated

Approved for marketing

VX-445/TEZ/IVA Expanded Access Program for Cystic Fibrosis (CF) Patients Heterozygous for F508del Mutation and a Minimal Function Mutation (F/MF Genotypes)

Cystic Fibrosis
Bausch & Lomb Incorporated

Completed

Evaluation of Clinical Outcomes Following Implantation of a Sub-2mm Hydrophilic MICS Intraocular Lens

Cataract

France
Cook Group Incorporated

Completed

Zilver PTX Post-Market Study in Japan

Peripheral Arterial Disease (PAD)
Bausch & Lomb Incorporated

Completed

Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant

Uveitis, Posterior

United States
Bausch & Lomb Incorporated

Terminated

A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)

Vitreoretinal Traction Syndrome

United States
Bausch & Lomb Incorporated

Completed

Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.

Cataract

United States
Vertex Pharmaceuticals Incorporated

Completed

A Phase 3 Study of Tezacaftor (VX-661) in Combination With Ivacaftor (VX-770) in Subjects Aged 12 Years and Older With Cystic Fibrosis (CF), Who Have One F508del-CFTR Mutation and a Second Mutation That Has Been Demonstrated to be Clinically Responsive to Ivacaftor

Cystic Fibrosis

United States, Australia, Canada, United Kingdom, Germany, Belgium, Austria, Ireland, Italy, France
Bausch & Lomb Incorporated

Completed

Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension (LUNAR)

Ocular Hypertension | Open-Angle Glaucoma

United States
Bausch & Lomb Incorporated

Completed

Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension (APOLLO)

Ocular Hypertension | Open-Angle Glaucoma

United States
Bausch & Lomb Incorporated

Completed

BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Constellation)

Ocular Hypertension | Open Angle Glaucoma

United States
Sound Pharmaceuticals, Incorporated

Unknown

A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss (PANIHL)

Noise Induced Hearing Loss

United States
Bausch & Lomb Incorporated

Completed

Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular Hypertension (Voyager)

Intraocular Pressure

United States
Vertex Pharmaceuticals Incorporated

Completed

A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation

Cystic Fibrosis

United States, Australia, Canada, Germany, Switzerland, Israel, Netherlands, Belgium, Italy, United Kingdom, France
Vertex Pharmaceuticals Incorporated

Completed

A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation

Cystic Fibrosis

United States, Canada, France, Spain, Israel, Australia, Austria
Neograft Technologies, Incorporated

Completed

The Angioshield Study Feasibility II

Coronary Artery Disease

Lithuania
Bausch & Lomb Incorporated

Completed

Efficacy of Latanoprostene Bunod in Lowering Intraocular Pressure in Japanese Healthy Male Volunteers (KRONUS)

Intraocular Pressure

United States
Torax Medical Incorporated

Completed

LINX Reflux Management System Clinical Study Protocol

Gastroesophageal Reflux

United States, Netherlands
Vertex Pharmaceuticals Incorporated

Completed

Study of VX-661 Alone and in Combination With Ivacaftor in Subjects Homozygous or Heterozygous to the F508del-Cystic Fibrosis Transmembrane Conductance Regulator(CFTR) Mutation

Cystic Fibrosis

United States, Canada, Germany, United Kingdom
Cook Group Incorporated

Completed

Zenith(R) Low Profile AAA Endovascular Graft Clinical Study

Abdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Iliac Aneurysms

United States, China, Germany, Sweden, Russian Federation
GlycoMimetics Incorporated
Celerion

Completed

A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects

Healthy Volunteers

United States

3

Subscribe